---
document_datetime: 2023-09-21 21:22:00
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/genvoya-epar-all-authorised-presentations_en.pdf
document_name: genvoya-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.2526668
conversion_datetime: 2025-12-30 12:28:55.65492
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical form Route of administration Immediate packaging Pack size

| EU/1/15/1061/003   | Genvoya   | 90 mg / 90 mg / 120 mg / 6 mg    | Film-coated tablet   | Oral use   | Bottle (HDPE)   | 30 tablets          |
|--------------------|-----------|----------------------------------|----------------------|------------|-----------------|---------------------|
| EU/1/15/1061/004   | Genvoya   | 90 mg / 90 mg / 120 mg / 6 mg    | Film-coated tablet   | Oral use   | Bottle (HDPE)   | 90 (3 x 30) tablets |
| EU/1/15/1061/001   | Genvoya   | 150 mg / 150 mg / 200 mg / 10 mg | Film-coated tablet   | Oral use   | Bottle (HDPE)   | 30 tablets          |
| EU/1/15/1061/002   | Genvoya   | 150 mg / 150 mg / 200 mg / 10 mg | Film-coated tablet   | Oral use   | Bottle (HDPE)   | 90 (3 x 30) tablets |